CTNNA2 and lung adenocarcinoma: Immune Microenvironment Characteristics of Catenin Alpha-2 Mutant-Type Patients in the Checkpoint Inhibitor-Treated Cohort and Cancer Genome Atlas-Lung Adenocarcinoma Cohort